VAXCYTE, INC. Preferred Stock, Dividends, Per Share, Cash Paid
VAXCYTE, INC. (PCVX) reported Preferred Stock, Dividends, Per Share, Cash Paid of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:PreferredStockDividendsPerShareCashPaid · last filed 2026-02-24
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for the quarter ending 2024-12-31 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for the quarter ending 2024-09-30 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for the quarter ending 2024-06-30 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for the quarter ending 2024-03-31 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for fiscal 2025 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for fiscal 2024 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for fiscal 2023 was $0.00.
- VAXCYTE, INC. preferred stock, dividends, per share, cash paid for fiscal 2022 was $0.00.
| Period end | Preferred Stock, Dividends, Per Share, Cash Paid 3 month | Preferred Stock, Dividends, Per Share, Cash Paid 6 month | Preferred Stock, Dividends, Per Share, Cash Paid 9 month | Preferred Stock, Dividends, Per Share, Cash Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |